Menopause is a natural reproductive stage
[3] Tirzepatide has a half-life of approximately 5 days, meaning the medication is substantially eliminated from the body within 23 weeks after the last dose
I also had rotator cuff surgery in 2022 that went wrong
PRAC Concludes Eye Condition NAION Is a Very Rare Side Effect of Semaglutide Medicines Ozempic, Rybelsus and Wegovy (June 6, 2025) Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide (July 3, 2024) Once-Weekly Semaglutide Doubles The Five-Year Risk Of Nonarteritic Anterior Ischemic Optic Neuropathy In A Danish Cohort Of 424,152 Persons With Type 2 Diabetes (December 18, 2024) Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide (January 30, 2025) Prevalence of Diabetic Retinopathy in the US in 2021 (June 15, 2023) Incidence Of Nonarteritic Anterior Ischemic Optic Neuropathy: Increased Risk Among Diabetic Patients (March 24, 2011) US FDA Package Insert: Ozempic US FDA Package Insert: Wegovy US FDA Package Insert: Zepbound US FDA Package Insert: Mounjaro
#ASNCJASN kidney.pub/CJASN1051 In a 24week study of 101 adults with CKD and excess weight, semaglutide 2.4 mg/week led to about 10% weight loss
